Early Release - Public Health Impact of Paxlovid as Treatment for COVID-19, United States - Volume 30, Number 2—February 2024 - Emerging Infectious Diseases journal - CDC
Bai Y, Du Z, Wang L, Lau E, Fung I, Holme P, Cowling B, Galvani A, Krug R, Meyers L. Early Release - Public Health Impact of Paxlovid as Treatment for COVID-19, United States - Volume 30, Number 2—February 2024 - Emerging Infectious Diseases journal - CDC. Emerging Infectious Diseases 2024, 30: 262-269. PMID: 38181800, PMCID: PMC10826746, DOI: 10.3201/eid3002.230835.Peer-Reviewed Original Research